Patents by Inventor Anne RIETZ

Anne RIETZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS
    Publication number: 20240173291
    Abstract: Compositions and methods are provided for treating HPV infections including pre-malignant and cancers. Compounds that specifically bind to the HPV E6 protein and inactivate the protein are disclosed.
    Type: Application
    Filed: December 14, 2023
    Publication date: May 30, 2024
    Inventors: ELLIOT J. ANDROPHY, SAMY MEROUEH, ZHIJIAN LU, Anne RIETZ
  • Small molecule antiviral drug treatment for human papillomavirus infections
    Patent number: 11877999
    Abstract: Compositions and methods are provided for treating HPV infections including pre-malignant and cancers. Compounds that specifically bind to the HPV E6 protein and inactivate the protein are disclosed.
    Type: Grant
    Filed: September 26, 2022
    Date of Patent: January 23, 2024
    Assignees: THE TRUSTEES OF INDIANA UNIVERSITY, KOVINA THERAPEUTICS, INC
    Inventors: Elliot J. Androphy, Samy Meroueh, Zhijian Lu, Anne Rietz
  • SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS
    Publication number: 20230047626
    Abstract: Compositions and methods are provided for treating HPV infections including pre-malignant and cancers. Compounds that specifically bind to the HPV E6 protein and inactivate the protein are disclosed.
    Type: Application
    Filed: September 26, 2022
    Publication date: February 16, 2023
    Inventors: ELLIOT J. ANDROPHY, SAMY MEROUEH, ZHIJIAN LU, Anne RIETZ
  • SMALL MOLECULE ANTIVIRAL DRUG TREATMENT FOR HUMAN PAPILLOMAVIRUS INFECTIONS
    Publication number: 20220142973
    Abstract: Compositions and methods are provided for treating HPV infections including pre-malignant and cancers. Compounds that specifically bind to the HPV E6 protein and inactivate the protein are disclosed.
    Type: Application
    Filed: January 19, 2022
    Publication date: May 12, 2022
    Inventors: ELLIOT J. ANDROPHY, SAMY MEROUEH, ZHIJIAN LU, Anne RIETZ